Author: Jonathan L. Prenner, MD
Description
CILIARY NEUROTROPHIC FACTOR THERAPY FOR MACULAR TELANGIECTASIA TYPE 2
2026-09-1407:58
TO DRAIN OR NOT TO DRAIN? THE MANCHESTER BUCKLE STUDY
2026-09-0806:56
RETINAL BLOOD VELOCITY AFTER INTRAVITREAL INJECTION FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH OPTICAL COHERENCE TOMOGRAPHY USING SPECKLE ANALYSIS
2026-08-2405:42
SURGICAL MANAGEMENT AND OUTCOMES OF LARGE HIGH MYOPIC MACULAR HOLES
2026-08-1406:43
INFLUENCE OF THE BASELINE MORPHOLOGIC STAGE ON POSTOPERATIVE VISUAL ACUITY AND METAMORPHOPSIA OUTCOMES IN FOVEA-OFF RHEGMATOGENOUS RETINAL DETACHMENT
2026-07-2804:05